__timestamp | Amicus Therapeutics, Inc. | Opthea Limited |
---|---|---|
Wednesday, January 1, 2014 | 20717000 | 2652041 |
Thursday, January 1, 2015 | 47269000 | 2361587 |
Friday, January 1, 2016 | 71151000 | 4472869 |
Sunday, January 1, 2017 | 88671000 | 5030957 |
Monday, January 1, 2018 | 127200000 | 4988941 |
Tuesday, January 1, 2019 | 169861000 | 5196412 |
Wednesday, January 1, 2020 | 156407000 | 6652774 |
Friday, January 1, 2021 | 192710000 | 18418247 |
Saturday, January 1, 2022 | 213041000 | 24827066 |
Sunday, January 1, 2023 | 275270000 | 41896408 |
Monday, January 1, 2024 | 15488619 |
Infusing magic into the data realm
In the competitive world of biotechnology, managing costs is crucial for success. This chart provides a fascinating insight into the Selling, General, and Administrative (SG&A) expenses of Opthea Limited and Amicus Therapeutics, Inc. over the past decade. From 2014 to 2023, Amicus Therapeutics has seen a staggering increase in SG&A expenses, growing by over 1,200%, peaking in 2023. In contrast, Opthea Limited's expenses have grown more modestly, with a notable spike in 2023, reaching nearly 42 million. This divergence highlights the different strategic approaches these companies have taken in managing their operational costs. While Amicus Therapeutics has consistently ramped up its spending, Opthea Limited has maintained a more conservative trajectory, with a significant jump in recent years. Understanding these trends can provide valuable insights into each company's operational strategies and market positioning.
SG&A Efficiency Analysis: Comparing AbbVie Inc. and Opthea Limited
Zoetis Inc. vs Amicus Therapeutics, Inc.: SG&A Expense Trends
Regeneron Pharmaceuticals, Inc. or Opthea Limited: Who Manages SG&A Costs Better?
BeiGene, Ltd. or Opthea Limited: Who Manages SG&A Costs Better?
Intra-Cellular Therapies, Inc. and Amicus Therapeutics, Inc.: SG&A Spending Patterns Compared
Bio-Techne Corporation or Amicus Therapeutics, Inc.: Who Manages SG&A Costs Better?
SG&A Efficiency Analysis: Comparing Opthea Limited and Protagonist Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing PTC Therapeutics, Inc. and Amicus Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of MorphoSys AG and Amicus Therapeutics, Inc.
Amicus Therapeutics, Inc. and Soleno Therapeutics, Inc.: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Amicus Therapeutics, Inc. and Iovance Biotherapeutics, Inc.
Comparing SG&A Expenses: Amicus Therapeutics, Inc. vs Evotec SE Trends and Insights